Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection

Luis Enrique Bermejo Galan; Nayara Melo dos Santos; Mauro Shosuka Asato; Jucineide Vieira Araújo; Adriana de Lima Moreira; Aléxia Mahara Marques Araújo; Artur Diogenes Pinheiro Paiva; Diego Guilherme Santos Portella; Frank Silas Saldanha Marques; Gabriel Melo Alexandre Silva; Joana de Sousa Resende; Marycassiely Rodrigues Tizolim; Poliana Lucenados Santos; Steffi Ferreira Buttenbender; Stephanye Batista de Andrade; Roberto Carlos Cruz Carbonell; Juliana Gomes Da Rocha; Ruy Guilherme Silveira de Souza; Allex Jardim da Fonseca

Pathogens and Global Health (2021) - Comments
pubmed: 33682640 doi: 10.1080/20477724.2021.1890887 issn: 2047-7724 issn: 2047-7732

Luis Enrique Bermejo Galan, Nayara Melo Dos Santos, Mauro Shosuka Asato, Jucineide Vieira Araújo, Adriana De Lima Moreira, Aléxia Mahara Marques Araújo, Artur Diogenes Pinheiro Paiva, Diego Guilherme Santos Portella, Frank Silas Saldanha Marques, Gabriel Melo Alexandre Silva, Joana De Sousa Resende, Marycassiely Rodrigues Tizolim, Poliana Lucenados Santos, Steffi Ferreira Buttenbender, Stephanye Batista De Andrade, Roberto Carlos Cruz Carbonell, Juliana Gomes Da Rocha, Ruy Guilherme Silveira De Souza, Allex Jardim Da Fonseca